Overall, these data suggest that, in lymphoma patients, the expansion of CD66b+CD33dimHLA-DR− cells within PBMCs is sustained by the proportional increment of the 3 subpopulations, with CD11b+CD16+ LDNs being the most represented. This evidence concerns the gene ITGAM and lymphoma.